Filter Results:
(355)
Show Results For
- All HBS Web
(355)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
Show Results For
- All HBS Web
(355)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
move to one of the big tech clusters like San Francisco,” Kerr says. “Likewise, if you are a biotech entrepreneur, there are enormous advantages to being in the Boston area. But there are also a lot of inventors who work in spaces that... View Details
Keywords: by Rachel Layne
- Web
Finalists | New Venture Competition
DoriVac (DNA Origami Vaccine) is a biotech startup for improving cancer treatment using a novel DNA nanoparticle platform. We develop treatments that teach patients' immune systems to recognize and fight cancer. Earthbond Chidalu Onyenso... View Details
- 10 May 2017
- Research & Ideas
Amazon Web Services Changed the Way VCs Fund Startups
cloud-based software and service companies, which could take advantage of AWS to decrease costs, versus others like biotechs that were less impacted by the new technologies. “The goal was to try and understand whether VCs were allocating... View Details
- 16 Feb 2004
- Research & Ideas
HBS Center Focuses on Europe
growth decisions facing Direvo, a young German biotech firm, when one of their partners suddenly wants to become an investor and the company expands both its customer and investor base in Europe and not just in Germany. Still a relatively... View Details
Keywords: by Cynthia Churchwell
- 01 Jun 2003
- News
Student Conferences, at a Glance
Jurvetson; Jeffrey C. Walker (MBA 1981), managing general partner, JPMorgan Partners; Stephen A. Schwarzman (MBA 1972), founding partner, president, & CEO, The Blackstone Group Fewer but better biotech companies are being funded with... View Details
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at... View Details
Keywords: Sean Silverthorne
- Web
Women on Boards: How Lara Druyan and Ann Lucena Are Shaping the Future of Corporate Leadership - Blog: RGE Report
“You need to be targeted; if you focus on too many things, you’re not focusing on anything.” Narrowing the field is always paramount, but it’s especially important when a company is in flux. As a director at Cerus Corporation—a biotech... View Details
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss View Details
Keywords: Sean Silverthorne
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
four-and-a-half year period. Problems involved everything from biotech to consumer products and agrochemicals. Thanks to broadcasting, nearly one-third of the previously unsolved problems found successful solutions. "Innovations... View Details
Keywords: by Martha Lagace
- 01 Sep 2008
- News
Balanced Equation
significantly. However, we remain a service organization helping entrepreneurs with disruptive technologies that create or transform business. KPCB has always focused on biotech and information technologies. Today we’ve added energy... View Details
- 19 Mar 2006
- Research & Ideas
Unlocking Your Investment Capital
Neither an asset's cost nor its size specifies its riskiness. For example, consider two assets, $1 billion of a single-drug biotech stock and $1 billion of U.S. Treasury bonds: Each has the same cost and size but they have radically... View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
deals with Bed Bath & Beyond, Frontier Airlines, and Johnson & Johnson. “You’re always asking, is this the right business model? But there are no answers. The market and technology are constantly changing,” Riesenfeld remarks. The biotech... View Details
- 01 Mar 2011
- News
Making Their Way
firm. But when her father fell ill in 1986, the Brownells decided to return to Detroit to help with the family enterprise founded by her great-grandfather. As things turned out, Brownell’s father recovered and was able to continue with the company. But Brownell, who in... View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how... View Details
Keywords: Martha Lagace
- 05 Aug 2016
- News
Accelerating Change on Medicine’s Final Frontier
program had two origins: Princeton engineering lecturer James Shinn (MBA 1981) and biotech entrepreneur Gregory Stock (MBA 1987), the brother of one of Amadio’s biology professors. “They impressed upon me how interesting it would be to... View Details
Keywords: Robert S. Benchley
- 08 Sep 2010
- First Look
First Look: September 8, 2010
for a cure; the doubts and obstacles he experiences along the way; and the current options Kremer faces, from returning home to spend time with family to founding a new biotech venture. Through this stark, realistic, and inspiring... View Details
Keywords: Sean Silverthorne
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for... View Details
Keywords: Sean Silverthorne
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
prescription drugs that in 1992 it spun off its remaining chemical business to its stockholders. In addition, the American Cyanamid purchase included Immunex, one of the very few biotech startups that had surpassed $100 million in... View Details
- 01 Oct 2000
- News
The Entrepreneurial Venture
instance, who are the customers, and how do they make decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging... View Details